Menu

Star on GitHub · 3.2k

CVE-2022-22919

6.1 · MEDIUM

Adenza AxiomSL ControllerView through 10.8.1 allows redirection for SSO login URLs.

Published Jan 30, 2022CWE-601EPSS 0.62%

Overview

CVE-2022-22919 is a medium-severity vulnerability. It was published on January 30, 2022 and has a CVSS 3.1 base score of 6.1 (MEDIUM).

This vulnerability has a CVSS 3.1 base score of 6.1, rated MEDIUM. It can be exploited remotely over the network. No authentication or special privileges are required for exploitation.

Technical description

Adenza AxiomSL ControllerView through 10.8.1 allows redirection for SSO login URLs.

Remediation

Check the references section for vendor advisories, patches, and mitigation guidance. If immediate patching is not possible, review the CVSS vector to understand the attack surface and apply compensating controls such as network segmentation or access restrictions.

Frequently asked questions

What is CVE-2022-22919?

CVE-2022-22919 is a medium-severity vulnerability. It was published on January 30, 2022 and has a CVSS 3.1 base score of 6.1 (MEDIUM).

How severe is CVE-2022-22919?

This vulnerability has a CVSS 3.1 base score of 6.1, rated MEDIUM. It can be exploited remotely over the network. No authentication or special privileges are required for exploitation.

How do I fix or remediate CVE-2022-22919?

Check the references section for vendor advisories, patches, and mitigation guidance. If immediate patching is not possible, review the CVSS vector to understand the attack surface and apply compensating controls such as network segmentation or access restrictions.

How can CyberStrike help with CVE-2022-22919?

CyberStrike is an open-source, AI-augmented pentesting engine. Rather than flag a version number, it tests whether an issue like CVE-2022-22919 is actually reachable in your own applications and APIs, then verifies each finding before reporting it. That tells you if the weakness is a real, exploitable risk in your environment or a false positive you can safely deprioritize.

Related MEDIUM CVEs from 2022

View all